Filing Details
- Accession Number:
- 0001209191-14-071964
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-01 17:06:19
- Reporting Period:
- 2014-11-28
- Filing Date:
- 2014-12-01
- Accepted Time:
- 2014-12-01 17:06:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1550395 | David Altshuler | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Transaction Summary
| Sold: | 3,500 shares | Avg. Price: $119.75 | Total Value: $419,125.00 |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-11-28 | 1,000 | $63.14 | 1,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-11-28 | 2,500 | $59.55 | 3,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-11-28 | 3,500 | $119.75 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-11-28 | 1,000 | $0.00 | 1,000 | $63.14 |
| Common Stock | Stock Option (right to buy) | Disposition | 2014-11-28 | 2,500 | $0.00 | 2,500 | $59.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,000 | 2022-05-23 | No | 4 | M | Direct | |
| 0 | 2022-05-31 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Dr. Altshuler's company approved trading plan under Rule 10b5-1.
- The option vests in 16 quarterly installments from 05/24/2012.
- Fully vested.
Billionaire Hedge Funds
